Action:
Waiver for e-prescribing of an opioid
General Information
| Action Summary |
Section 21 is added to Chapter 21 to: 1) reiterate the requirement that takes effect on July 1, 2020 that a prescription for a controlled substance that contains an opioid must be issued as an electronic prescription; and 2) provide for a one-year from the requirement if the practitioner can demonstrate economic hardship technological limitations or other exceptional circumstances beyond the practitioner’s control. |
| Chapters Affected |
Only affects this chapter.
|
| Exempt from APA |
No, this action is not exempt from Article II of the APA and executive branch review.
|
| RIS Project |
Yes [006085] |
| Associated Mandates |
Waiver for electronic prescribing
|
| New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
| Stage ID |
Stage Type |
Status |
|
8714
|
Emergency/NOIRA
|
Stage complete. This regulation became effective on 09/18/2019 and expires on 03/17/2021. |
Contact Information
|
Name / Title:
|
William L. Harp, M.D.
/
Executive Director
|
|
Address:
|
9960 Mayland Drive
Suite 300
Richmond, VA 23233
|
|
Email Address:
|
william.harp@dhp.virginia.gov
|
|
Phone:
|
(804)367-4558
FAX: (804)527-4429
TDD: ()-
|
This person is the primary contact for this board.
Agencies | Governor
